ISPR vs PATH
Ispire Technology Inc. Common Stock (ISPR) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Ispire Technology Inc. Common Stock (ISPR) is a tobacco company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported ISPR revenue for 2025-06-30 was $127.5M. Net income was -$39.2M. Revenue was down 16.1% from 2024-06-30 to 2025-06-30. ISPR currently screens at market cap $170.3M.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
ISPR currently screens at market cap $170.3M. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the ISPR and PATH stock pages for the full models.
Not investment advice.